Therapeutic targeting of polo-like kinase 1 using RNA-interfering nanoparticles (iNOPs) for the treatment of non-small cell lung cancer
Joshua A. McCarroll(Cancer Institute of New South Wales), Maria Kavallaris(Cancer Institute of New South Wales)
Cited by 60
Related Papers
Taxol-resistant epithelial ovarian tumors are associated with altered expression of specific beta-tubulin isotypes.
|Journal of Clinical Investigation|1997|598
Biologically Targeted Magnetic Hyperthermia: Potential and Limitations
|Frontiers in Pharmacology|2018|482
Microtubules and Their Role in Cellular Stress in Cancer
|Frontiers in Oncology|2014|464